103 related articles for article (PubMed ID: 34587729)
21. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
22. Circulating Levels of Irisin in Hypopituitary and Normal Subjects.
Pena-Bello L; Pértega-Diaz S; Sangiao-Alvarellos S; Outeiriño-Blanco E; Eiras-Leal R; Varela-Rodriguez B; Juiz-Valiña P; Pérez-Fontán M; Cordido M; Cordido F
PLoS One; 2016; 11(7):e0160364. PubMed ID: 27472279
[TBL] [Abstract][Full Text] [Related]
23. A therapeutic trial of growth hormone in hypopituitary adults and its influence upon continued prescription by general practitioners.
Davies JS; Obuobie K; Smith J; Rees DA; Furlong A; Davies N; Evans LM; Scanlon MF
Clin Endocrinol (Oxf); 2000 Mar; 52(3):295-303. PubMed ID: 10718827
[TBL] [Abstract][Full Text] [Related]
24. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
Abs R; Feldt-Rasmussen U; Mattsson AF; Monson JP; Bengtsson BA; Góth MI; Wilton P; Koltowska-Häggström M
Eur J Endocrinol; 2006 Jul; 155(1):79-90. PubMed ID: 16793953
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
[TBL] [Abstract][Full Text] [Related]
26. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
[TBL] [Abstract][Full Text] [Related]
27. Elderly people with hypothalamic-pituitary disease and untreated GH deficiency: clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls.
Li Voon Chong JS; Groves T; Foy P; Wallymahmed ME; MacFarlane IA
Clin Endocrinol (Oxf); 2002 Feb; 56(2):175-81. PubMed ID: 11874408
[TBL] [Abstract][Full Text] [Related]
28. Similar clinical features among patients with severe adult growth hormone deficiency diagnosed with insulin tolerance test or arginine or glucagon stimulation tests.
Toogood A; Brabant G; Maiter D; Jonsson B; Feldt-Rasmussen U; Koltowska-Haggstrom M; Rasmussen AK; Buchfelder M; Saller B; Biller BM
Endocr Pract; 2012; 18(3):325-34. PubMed ID: 22068248
[TBL] [Abstract][Full Text] [Related]
29. Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study.
Smith JC; Evans LM; Wilkinson I; Goodfellow J; Cockcroft JR; Scanlon MF; Davies JS
Clin Endocrinol (Oxf); 2002 Apr; 56(4):493-501. PubMed ID: 11966742
[TBL] [Abstract][Full Text] [Related]
30. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
[TBL] [Abstract][Full Text] [Related]
31. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
Christiansen JJ; Fisker S; Gravholt CH; Bennett P; Svenstrup B; Andersen M; Feldt-Rasmussen U; Christiansen JS; Jørgensen JO
Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
[TBL] [Abstract][Full Text] [Related]
32. [The prevalence of metabolic syndrome in middle-aged in Kaunas population].
Gustiene O; Slapikas R; Klumbiene J; Sakalauskiene G; Kubilius R; Bagdzeviciūte S; Zaliūnas R
Medicina (Kaunas); 2005; 41(10):867-76. PubMed ID: 16272835
[TBL] [Abstract][Full Text] [Related]
33. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.
al-Shoumer KA; Cox KH; Hughes CL; Richmond W; Johnston DG
J Clin Endocrinol Metab; 1997 Aug; 82(8):2653-9. PubMed ID: 9253349
[TBL] [Abstract][Full Text] [Related]
34. Metabolic syndrome in HIV infected adults in Poland.
Rogalska-Płońska M; Grzeszczuk A; Rogalski P; Łucejko M; Flisiak R
Kardiol Pol; 2018; 76(3):548-553. PubMed ID: 29350379
[TBL] [Abstract][Full Text] [Related]
35. Secondary IGF-I deficiency as a prognostic factor of growth hormone (GH) therapy effectiveness in children with isolated, non-acquired GH deficiency.
Smyczyńska J; Stawerska R; Hilczer M; Lewiński A
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):209-14. PubMed ID: 25607339
[TBL] [Abstract][Full Text] [Related]
36. Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled study.
Christ ER; Cummings MH; Lumb PJ; Crook MA; Sönksen PH; Russell-Jones DL
Clin Endocrinol (Oxf); 1999 Aug; 51(2):173-9. PubMed ID: 10468987
[TBL] [Abstract][Full Text] [Related]
37. Effects of obesity surgery on the metabolic syndrome.
Lee WJ; Huang MT; Wang W; Lin CM; Chen TC; Lai IR
Arch Surg; 2004 Oct; 139(10):1088-92. PubMed ID: 15492149
[TBL] [Abstract][Full Text] [Related]
38. [Lowered ghrelin levels in acromegaly—normalization after treatment].
Kozakowski J; Rabijewski M; Zgliczyński W
Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone (GH) status is an independent determinant of serum levels of cholesterol and triglycerides in healthy adults.
Vahl N; Klausen I; Christiansen JS; Jørgensen JO
Clin Endocrinol (Oxf); 1999 Sep; 51(3):309-16. PubMed ID: 10469010
[TBL] [Abstract][Full Text] [Related]
40. [Association between endometrial cancer and metabolic syndrome].
Shou HF; Ni J; Zhu T; Chen JH; Zhang X; Xu XX; Chen L; Yu H
Zhonghua Fu Chan Ke Za Zhi; 2010 Feb; 45(2):128-31. PubMed ID: 20420784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
